Sutro Biopharma (STRO)

Sutro Biopharma (STRO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $181M; returns 1 day -9.3%, 1 week -14.7%, 1 year -12.0%.

Sutro Biopharma, Inc. (NASDAQ: STRO) is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of cancer therapeutics, primarily utilizing its proprietary cell-free protein synthesis platform, XpressCF® and XpressCF+.

Groups STRO belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Antibody-Drug Conjugates
• Oncology
• Cancer Therapeutics
• Healthcare
• Biopharmaceutical
• Life Sciences
• Antibody Therapeutics
• Drug Discovery
• Precision Medicine
• R&D

STRO financial model: income statement, cash flow and balance sheet